SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-16-796197
Filing Date
2016-12-19
Accepted
2016-12-16 20:54:04
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B4 d271779d424b4.htm 424B4 943926
2 GRAPHIC g271779g27z79.jpg GRAPHIC 31712
3 GRAPHIC g271779g37s23.jpg GRAPHIC 148017
4 GRAPHIC g271779g38v62.jpg GRAPHIC 49875
  Complete submission text file 0001193125-16-796197.txt   1261510
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-214199 | Film No.: 162057677
SIC: 2834 Pharmaceutical Preparations